metanephrine has been researched along with Goiter, Nodular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrási, M; Barna, S; Berta, E; Bhattoa, HP; Bodor, M; Erdei, A; Gazdag, A; Győry, F; Hircsu, I; Kanyári, Z; Nagy, B; Nagy, VE | 1 |
| Pekkolay, Z; Tuzcu, SA | 1 |
2 other study(ies) available for metanephrine and Goiter, Nodular
| Article | Year |
|---|---|
[Multiple endocrine neoplasia type 2A in a family].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Female; Goiter, Nodular; Humans; Metanephrine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Parathyroid Neoplasms; Pheochromocytoma; Ribosomal Proteins; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy | 2020 |
Multiple endocrine neoplasia type 2A syndrome (MEN2A) and usefulness of 68Ga-DOTATATE PET/CT in this syndrome.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Catecholamines; Female; Gallium Radioisotopes; Goiter, Nodular; Humans; Male; Metanephrine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tissue Distribution | 2019 |